<?xml version="1.0" encoding="UTF-8"?>
<ref id="B9" class="ref">
 <mixed-citation publication-type="journal" class="mixed-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Uhrin</surname>
    <given-names class="given-names">P.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Wang</surname>
    <given-names class="given-names">D.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Mocan</surname>
    <given-names class="given-names">A.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Waltenberger</surname>
    <given-names class="given-names">B.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Breuss</surname>
    <given-names class="given-names">J. M.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Tewari</surname>
    <given-names class="given-names">D.</given-names>
   </name>
   <etal class="etal"/>
  </person-group>. (
  <year class="year">2018</year>). 
  <article-title class="article-title">Vascular smooth muscle cell proliferation as a therapeutic target. Part 2: natural products inhibiting proliferation</article-title>. 
  <source class="source">Biotechnol. Adv.</source>
  <volume class="volume">36</volume>:
  <fpage class="fpage">1608</fpage>â€“
  <lpage class="lpage">21</lpage>. 
  <pub-id pub-id-type="doi" class="pub-id">10.1016/j.biotechadv.2018.04.002</pub-id>
  <?supplied-pmid 29678389?>
  <pub-id pub-id-type="pmid" class="pub-id">29678389</pub-id>
 </mixed-citation>
</ref>
